Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancer
Yoshito Komatsu(Hokkaido University Hospital), Atsushi Ohtsu(National Cancer Center Hospital East)
Cited by 30
Related Papers
No related papers found
Powered by citation graph analysis